Position in NVS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$267,207
+$6,769 QoQ
Shares Held
1,705
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,189
of 1,602 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Argent Advisors, Inc. holds $22,940,677 across 9 Drug Manufacturers - General names. NVS ranks #9 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,391 | $5,266,697 | |
| 2 | JNJ |
Johnson & Johnson
|
20,074 | $5,098,193 | |
| 3 | MRK |
Merck & Co., Inc.
|
24,547 | $3,154,289 | |
| 4 | GSK |
GSK plc
|
51,943 | $2,722,852 | |
| 5 | PFE |
Pfizer Inc
|
109,643 | $2,640,203 | |
| 6 | AMGN |
Amgen Inc
|
4,586 | $1,660,682 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
11,701 | $1,478,304 | |
| 8 | ABBV |
AbbVie Inc.
|
2,592 | $652,250 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $267,207 | 1,705 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $260,438 | 1,705 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $421,606 | 3,058 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $392,157 | 3,058 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $323,096 | 2,670 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $319,167 | 2,863 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $260,109 | 2,673 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $307,448 | 2,673 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $355,895 | 3,343 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $323,368 | 3,343 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $292,106 | 2,893 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $336,443 | 3,303 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $333,305 | 3,303 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $303,876 | 3,303 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $290,576 | 3,203 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $243,460 | 3,203 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $262,296 | 3,103 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $274,306 | 3,126 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $273,431 | 3,126 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $255,644 | 3,126 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $273,355 | 2,996 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $230,454 | 2,696 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $351,185 | 3,719 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $313,142 | 3,601 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $267,784 | 3,066 | Shares | Sole | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||